17. Multiple system atrophy
107 clinical trials,   153 drugs   (DrugBank: 48 drugs),   59 drug target genes,   104 drug target pathways

Searched query = "Multiple system atrophy", "MSA-C", "MSA-P", "Olivopontocerebellar atrophy", "OPCA", "Striatonigral degeneration", "Shy-Drager syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02591173
(ClinicalTrials.gov)
February 201627/10/2015Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic FailureBlood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic FailureAutonomic Nervous System Disorders;Pure Autonomic Failure;Shy-Drager Syndrome;Orthostatic Hypotension, DysautonomicDrug: Angiotensin-(1-7);Drug: SalineVanderbilt University Medical CenterNULLRecruiting18 Years80 YearsAll22Early Phase 1United States
2NCT01292694
(ClinicalTrials.gov)
March 20118/2/2011Contribution of Angiotensin II to Supine Hypertension in Autonomic FailureContribution of Angiotensin II to Supine Hypertension in Autonomic FailureHypertension;Pure Autonomic Failure;Multiple System AtrophyDrug: Losartan;Drug: Captopril;Drug: PlaceboVanderbilt UniversityNULLTerminated18 Years85 YearsAll12Phase 1United States